Evidence map›Paper›PMID 40274670›Full record

ReviewNeotropical entomology2025

Over 10 Years of Bt Soybean in Brazil: Lessons, Benefits, and Challenges for Its Use in Integrated Pest Management (IPM).

Adeney de Freitas Bueno, Erica Caroline Braz-Zini, Renato J Horikoshi, Oderlei Bernardi, Galdino Andrade, Weidson Plauter Sutil

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neotropical entomology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adeney de Freitas BuenoEmpresa Brasileira de Pesquisa Agropecuária - Embrapa Soja, Londrina, Paraná, Brazil. adeney.bueno@embrapa.br.ORCID http://orcid.org/0000-0002-5462-5845
Erica Caroline Braz-ZiniUniv Estadual de Londrina (UEL), Londrina, Paraná, Brazil.
Renato J HorikoshiBayer Crop Science - São Paulo, São Paulo, Brazil.
Oderlei BernardiUniv Federal de Santa Maria (UFSM), Santa Maria, Rio Grande Do Sul, Brazil.
Galdino AndradeUniv Estadual de Londrina (UEL), Londrina, Paraná, Brazil.
Weidson Plauter SutilUniv Federal Do Paraná (UFPR) - Curitiba, Curitiba, Paraná, Brazil.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 304052/2021-3
6 · The paper itself

Abstract

Commercially available in Brazil since the 2013/2014 crop season, the adoption of Bt soybean rapidly increased to > 80% after only eight crop seasons (2020/2021). The widespread use of Bt soybean has achieved regional suppression of key lepidopteran pests and reduced insecticide use, providing economic and environmental benefits for all in Brazilian agriculture. Due to the high efficacy of Bt soybean in controlling key soybean lepidopteran pests and the simplicity of its use, most soybean farmers have adopted Bt soybean in extensive areas, reaching 94% adoption in the 2023/2024 crop season. However, the high adoption of Bt soybean associated with low refuge compliance has led to the first cases of pest resistance to Cry1Ac (Crocidosema sp. and Rachiplusia nu) in Brazil, representing major challenges to the future of this technology. Unfortunately, farmers wrongly believe that non-Bt soybean cultivars cannot be as profitable and productive as Bt soybean cultivars. Therefore, more than 10 years after Bt soybean adoption in Brazil, this review discusses the most important benefits and challenges of Bt soybean use and what can be expected for the next decade of this technology.

Indexed as

Glycine maxPest Control, BiologicalPlants, Genetically ModifiedAgricultureAnimalsBacillus thuringiensis ToxinsBrazilLepidopteraTime FactorsBacillus thuringiensis ToxinsBiological controlCry1 Ac soybeanSoybean pest managementSustainability

Identifiers

PMID40274670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.